Deceased Plaintiffs' Families Must Produce PICA Diagnosis in Taxotere MDL, Judge Rules

NEW ORLEANS — The judge overseeing the federal MDL docket for Taxotere (docetaxel) permanent hair loss litigation has refused to vacate or modify an order requiring the families of deceased plaintiffs to submit evidence of a medical diagnosis of permanent chemotherapy-induced alopecia (PCIA).

On Oct, 1, Judge Jane T. Milazzo of the U.S. District Court for the Eastern District of Louisiana explained that the order’s requirements are reasonable and that plaintiffs have failed to show why they need additional time to comply with the order.

Plaintiffs allege that Taxotere, manufactured by Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, caused …